Clinical trial
The Application of Comprehensive Prevention and Treatment Strategy of Placenta Accreta Spectrum Disorders
NCT06477497 is registered in ClinicalTrials.gov with Peking Union Medical College Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- The Application of Comprehensive Prevention and Treatment Strategy of Placenta Accreta Spectrum Disorders
- Lead sponsor
- Peking Union Medical College Hospital
- Phase
- Observational
- Overall status
- Unknown status
- Start date
- July 1, 2024
- Completion date
- November 30, 2025
- Enrollment
- 33 (estimated)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.
placenta accreta spectrum